Outcome of adalimumab monotherapy in paediatric non-infectious uveitis

Outcome of adalimumab monotherapy in paediatric non-infectious uveitis

Abstract Background Adalimumab in combination with other disease-modifying antirheumatic drugs (DMARD) such as methotrexate has a proven efficacy in the management of paediatric non-infectious uveitis. However, many children experience significant intolerance to methotrexate while on this combinatio...

Descripció completa

Dades bibliogràfiques
Autors principals: DA Al-Julandani, NK Bagri, N Tsang, S Clarke, A Upadhyay, C Guly, AV Ramanan
Format: Article
Idioma:English
Publicat: BMC 2023-03-01
Col·lecció:Pediatric Rheumatology Online Journal
Matèries:
Non-infectious uveitis
Paediatrics
Adalimumab monotherapy
JIA-uveitis
Accés en línia:https://doi.org/10.1186/s12969-023-00794-y

Internet

https://doi.org/10.1186/s12969-023-00794-y

Ítems similars